NCT00003396
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +60 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
Clinical trial condition
Waldenstrom Macroglobulinemia
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
395 public trials
46 recruiting studies
Waldenstrom Macroglobulinemia trial results
NCT00003398
- Conditions
- Anemia, Blast Crisis, Blood Protein Disorders, +64 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
NCT01076543
- Conditions
- AIDS-Related Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT01429025
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States
- Mercy Cancer Center-West Lakes Clive, Iowa, United States
- Iowa Methodist Medical Center Des Moines, Iowa, United States
- Iowa Oncology Research Association CCOP Des Moines, Iowa, United States
NCT01529827
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00005799
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- University of Colorado Denver, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States
NCT00474929
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
- Locations
-
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01839916
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
NCT01282424
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- St. Jude Medical Center Fullerton, California, United States
- Pacific Shores Medical Group Long Beach, California, United States
- UCLA Los Angeles, California, United States
- Central Coast Medical Oncology Santa Maria, California, United States